Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trial (Q36197026)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trial |
scientific article |
Statements
1 reference
Sunitinib plus paclitaxel versus bevacizumab plus paclitaxel for first-line treatment of patients with advanced breast cancer: a phase III, randomized, open-label trial (English)
1 reference
Nicholas J Robert
1 reference
Mansoor N Saleh
1 reference
Devchand Paul
1 reference
Daniele Generali
1 reference
Laurent Gressot
1 reference
Mehmet S Copur
1 reference
Adam M Brufsky
1 reference
Susan E Minton
1 reference
Jeffrey K Giguere
1 reference
John W Smith
1 reference
Paul D Richards
1 reference
Diana Gernhardt
1 reference
Xin Huang
1 reference
Katherine F Liau
1 reference
Kenneth A Kern
1 reference
John Davis
1 reference
1 reference
Identifiers
1 reference